Welcome to glp.space — an independent, educational platform operated by Ex Automata, Inc., a company based in the United States.

We provide fact-checked, evidence-based information about GLP-1 medication providers in the United Kingdom to help people understand their options for treatments like Wegovy and Mounjaro.

We’re not a pharmacy, clinic, or medical service. glp.space exists purely to educate, compare, and inform. We don’t prescribe, sell, or dispense medication — and we don’t replace medical advice from a qualified professional.

Cross-Border Notice:

glp.space is operated by a U.S.-based company and provides independent comparison and educational content intended for UK audiences. While we comply with UK advertising and healthcare communication standards, we are not a medical, prescribing, or pharmacy service, and we do not dispense or sell medications.

All information is for educational purposes only, and users should always verify details with licensed UK professionals and official regulatory bodies (MHRA, GPhC, CQC).

By using glp.space, you agree to these Terms and Conditions.

All information on glp.space is provided for educational and informational purposes only.

Some links on glp.space are affiliate links, meaning we may receive a small commission if you make a purchase through them.

This does not:

• Affect the price you pay
• Influence our comparisons or recommendations
• Compromise our editorial independence

Affiliate relationships are managed under U.S. Federal Trade Commission (FTC) guidelines, and we voluntarily comply with UK ASA/CAP transparency rules.

All content on glp.space — text, images, graphics, logos, and design — is the property of Ex Automata, Inc. or our content partners.

You may:

• View and share our pages for personal use
• Quote brief excerpts with proper credit and link back

You may not:

• Copy or reproduce substantial portions of our site
• Use our materials commercially without written consent
• Remove copyright or attribution information

Our educational content is based on peer-reviewed research, NICE guidance, MHRA authorisations, and reputable medical studies. If you spot an inaccuracy, please let us know.

glp.space includes links to third-party websites such as:

• UK pharmacies and healthcare providers
• NHS and NICE resources
• MHRA, CQC, and GPhC regulatory bodies

While we include these links for convenience, we have no control over external sites. A link does not mean endorsement. Always check their privacy policies and Terms before use.

We strive to keep all information on glp.space:

• Accurate and current
• Based on reliable, verifiable sources
• Reviewed in line with MHRA and NICE guidance

However, we cannot guarantee that:

• All data is always complete or up-to-date
• Provider information or pricing remains unchanged
• Research findings don’t evolve over time

We encourage you to:

• Verify key information directly
• Consult healthcare professionals for medical decisions
• Notify us of any errors or outdated information

To the fullest extent permitted by law, Ex Automata, Inc. and glp.space are not liable for:

• Any loss, injury, or damage arising from your use of our website
• Actions or omissions of third-party providers
• Interruptions, errors, or downtime
• Reliance on educational information presented here
• Medical outcomes or side effects from medications

By using glp.space, you acknowledge that:

• You are solely responsible for your healthcare decisions
• You will consult qualified professionals before taking any medication
• You will verify all information independently

Nothing in these Terms excludes liability for fraud, negligence causing death or injury, or any right that cannot be excluded by law.

Ex Automata, Inc. operates from the United States and complies with applicable U.S. privacy laws.

For visitors from the United Kingdom and the European Union, we follow the principles of the UK GDPR and EU GDPR, ensuring fair and transparent data handling.

We:

• Do not collect browsing data beyond analytics
• Only store information voluntarily submitted (e.g., Contact Form)
• Never sell or share data with third parties

If we begin processing substantial UK or EU personal data, we will appoint a UK/EU representative in line with Article 27 of GDPR.

For full details, please read our Privacy Policy.

If you believe any content on glp.space is inaccurate, infringes copyright, or violates UK advertising or data rules, please contact us at [email protected].

We review all legitimate concerns and will respond within 14 working days.

We may update these Terms and Conditions when:

• UK or US regulations change
• Our services or content evolve
• We need to improve clarity or accuracy

Whenever we make significant updates:

• We’ll update the “Last Updated” date above
• Continued use of glp.space means you accept the new Terms

These Terms are governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to conflict of law principles.

Although we operate under U.S. jurisdiction, we strive to comply with UK consumer protection and advertising standards — including ASA, MHRA, and CAP guidance — for transparency and fairness to our UK readers.

Ex Automata, Inc.
Operator of glp.space

• Email: [email protected]
• Address: 2261 Market Street San Francisco, CA, 94114 United States
• Website: glp.space/contact

Thank you for visiting glp.space. Our mission is to provide accurate, transparent, and responsible information to help people make informed choices about GLP-1 treatments in the UK.